What is the recommended dose of metronidazole (Flagyl) oral for a female patient of childbearing age with Bacterial Vaginosis (BV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole Dosing for Bacterial Vaginosis

For non-pregnant women of childbearing age with bacterial vaginosis, the recommended dose is metronidazole 500 mg orally twice daily for 7 days. 1

Standard Oral Regimen

  • Metronidazole 500 mg orally twice daily for 7 days is the first-line treatment recommended by the Centers for Disease Control and Prevention. 1
  • This regimen achieves cure rates of approximately 78-87% and provides both symptom relief and microbiologic cure. 1, 2
  • The 7-day course is more effective than single-dose therapy and should be preferred for initial treatment. 1

Alternative Oral Regimens

If the standard regimen cannot be used, consider these alternatives:

  • Metronidazole 2 g orally as a single dose is an alternative option, though it has lower efficacy compared to the 7-day course. 1
  • Clindamycin 300 mg orally twice daily for 7 days is another alternative with comparable efficacy (cure rate 93.9%). 1

Topical Alternatives

For patients who prefer or require topical therapy:

  • Metronidazole gel 0.75%, one full applicator (5 g) intravaginally once daily for 5 days is equally effective to oral therapy. 1, 3
  • Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days achieves cure rates of 72-82%. 1, 2

Critical Patient Counseling

  • Patients must avoid all alcohol consumption during metronidazole treatment and for 24 hours after completion to prevent disulfiram-like reactions (flushing, nausea, vomiting, headache). 1, 3
  • Clindamycin cream and ovules are oil-based and will weaken latex condoms and diaphragms for several days after use; patients need alternative contraception during this period. 1

Special Considerations for Pregnancy

The dosing differs significantly in pregnant women:

  • Metronidazole 250 mg orally three times daily for 7 days is the recommended regimen for pregnant women (after first trimester). 4, 1
  • Lower doses are used in pregnancy to minimize fetal exposure while maintaining efficacy. 4
  • Metronidazole is contraindicated in the first trimester; clindamycin vaginal cream should be used instead during this period. 1, 3

Follow-Up and Partner Management

  • No follow-up visit is necessary if symptoms resolve completely. 1, 5
  • Routine treatment of male sex partners is not recommended, as clinical trials demonstrate that partner treatment does not affect cure rates or reduce recurrence. 1, 6

Common Pitfall to Avoid

Do not confuse BV dosing with trichomoniasis dosing—while metronidazole 2 g single dose is standard for trichomoniasis, the 7-day regimen of 500 mg twice daily is preferred for BV due to superior efficacy. 1, 7

References

Guideline

Bacterial Vaginosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metronidazole Gel Treatment for Bacterial Vaginosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metronidazole Vaginal Gel Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Bacterial vaginosis: review of treatment options and potential clinical indications for therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999

Research

Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.